Temozolomide Gliogen 250mg Tablet

Name: Temozolomide Gliogen 250mg Tablet
Brand: Welox Pharma Private Limited
Price: 5500 INR
Availability: InStock

Price 5500 INR/ Bottle

Get a Price/Quote

MOQ : 100 Bottles

Temozolomide Gliogen 250mg Tablet Specification

Salt Composition
Temozolomide (250mg)

Brand Name
Gliogen 250

Origin of Medicine
India

Pacakaging (Quantity Per Box)
5 tablets

Indication
Malignant glioma and glioblastoma

Dosage Form
Oral tablet

Life Span
24 Month

Packaging Type
Strip

Drug Type
Antineoplastic

Ingredients
Temozolomide

Physical Form
Tablet

Function
Anticancer agent

Recommended For
Brain tumor patients

Dosage
As directed by physician

Dosage Guidelines
Prescription only

Suitable For
Adults

Quantity
250 mg

Storage Instructions
Store below 25C, protected from moisture

Shape
Capsule-shaped

Tablet Count
5 per pack

Prescription
Required

Route
Oral use

Strength
250 mg

Color
White

Temozolomide Gliogen 250mg Tablet Trade Information

Minimum Order Quantity
100 Bottles

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Bottles Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Temozolomide Gliogen 250mg Tablet

Discover the lofty benefits and stellar innovation of Temozolomide Gliogen 250mg Tablet - your last chance for exclusive savings on a champion antineoplastic solution! Specially formulated for adult brain tumor patients, this prescription-only, capsule-shaped white tablet is your ally in the fight against malignant glioma and glioblastoma. Each strip contains 5 potent tablets, delivering 250mg of Temozolomide per dose. With a pharmaceutical pedigree from India's renowned manufacturers and a shelf life of 24 months, Gliogen 250 remains an exceptional and trusted choice.

Exceptional Features and Targeted Application

Temozolomide Gliogen 250mg Tablet stands out with its exclusive pharmaceutical formulation, designed for adult patients battling malignant brain tumors. As a white, capsule-shaped oral tablet, its application surface is internal, targeting brain glioma and glioblastoma at a cellular level. Its antineoplastic properties help inhibit tumor growth, guided by physician-supervised dosage protocols. Each pack contains 5 tablets, ensuring controlled and convenient treatment with stringent storage directions to maintain efficacy.

Domestic and Global Market Reach and Sample Availability

With the new arrival of Gliogen 250, our product is readily available in India's main domestic markets and select global destinations. Interested buyers can request a sample before purchase, with competitive asking prices provided on inquiry. We ensure swift dispatching for bulk and repeat orders. Whether you are a distributor, clinic, or healthcare provider, Gliogen 250 assures dependable availability and prompt delivery in both domestic and export channels.

FAQ's of Temozolomide Gliogen 250mg Tablet:

Q: How should Temozolomide Gliogen 250mg Tablet be stored for optimal efficacy?

A: Store the tablets below 25C and protect them from moisture to maintain their effectiveness throughout the shelf life.

Q: What is the primary usage of Temozolomide Gliogen 250mg Tablet?

A: This medication is primarily used for treating adult patients with malignant glioma and glioblastoma brain tumors, as prescribed by a physician.

Q: When is it recommended to take Temozolomide Gliogen 250mg Tablet?

A: Take the tablet exactly as directed by your healthcare provider, following their prescribed schedule and dosage guidelines.

Q: Where is Temozolomide Gliogen 250mg Tablet manufactured?

A: Gliogen 250 is manufactured, supplied, and traded by trusted pharmaceutical facilities in India, maintaining high standards of quality.

Q: What is the process for ordering or sampling Temozolomide Gliogen 250mg Tablet?

A: Prospective buyers can inquire for asking prices and request product samples, with quick dispatching arrangements for both domestic and international orders.

Q: What are the benefits of using Temozolomide Gliogen 250mg Tablet?

A: Its main benefit is its proven effectiveness as an antineoplastic agent for slowing tumor growth in brain cancer patients, under expert medical supervision.